Dave Stevenson
Managing Director @ Merck Global Health Innovation Fund
Philadelphia, United States
Dave Stevenson is a Series A investor at Merck Global Health Innovation Fund in Philadelphia focused on Health Care and Pharmaceutical. Dave Stevenson is and investment principle responsible for identifying investment opportunities in emerging healthcare solutions and services.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Dave Stevenson invests in
Stages Dave Stevenson invests in
Countries Dave Stevenson invests in
Investment Focus
Industry
- Health Care 1 (50%)
- Pharmaceutical 1 (50%)
- Information Services 1 (50%)
- Information Technology 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ayogo Health
|
Ayogo is a global leader in the application of behavioral psychology and social gaming to improve health outcomes for patients. Healthier patients improve financial outcomes. Insurers, healthcare providers, ACOs and pharmaceutical companies are Ayogo’s clients. All of our projects begin with meaningful collaboration with patients, end-users andclients. Our corporate culture fosters excellence and thoughtful creation. We maintain the open culture of a startup at our studio in Vancouver’s Centre for Digital Media where our software engineers, user-experience designers, artists and other experts in patient engagement work together. | $7.5M / Series B / May 01, 2020 | |
|
Ayogo Health
|
Ayogo is a global leader in the application of behavioral psychology and social gaming to improve health outcomes for patients. Healthier patients improve financial outcomes. Insurers, healthcare providers, ACOs and pharmaceutical companies are Ayogo’s clients. All of our projects begin with meaningful collaboration with patients, end-users andclients. Our corporate culture fosters excellence and thoughtful creation. We maintain the open culture of a startup at our studio in Vancouver’s Centre for Digital Media where our software engineers, user-experience designers, artists and other experts in patient engagement work together. | Series A / Apr 07, 2015 |
Co-Investors
About Merck Global Health Innovation Fund
Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions.Merck GHI has $500M under management and provides growthcapital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck.With a vision that data will be the currency in healthcare, GHI invests broadly in digital health. GHI invests in platform companies with proven technologies or business models where Merck's expertise and perspectives can accelerate revenue growth and enhance value creation. Since late 2010, Merck GHI has made over 20 investments in Digital Health companies.
Merck Global Health Innovation Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Bill Taranto
Founder, President & General Partner
|
|||
Bill Taranto
Founder, President & General Partner
|
|||
|
Dave Stevenson
Managing Director
|
|||
Joe Volpe
Managing Director and Founding Partner
|
|||
David M. Rubin
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Dave Stevenson invest in?
Dave Stevenson invests primarily in Health Care, Pharmaceutical and Information Services startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Dave Stevenson last invest?
The most recent investment recorded for Dave Stevenson closed in May 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
